Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia.
about
Stenotrophomonas maltophilia: an emerging global opportunistic pathogenEvaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill ExperimentsCotrimoxazole - optimal dosing in the critically ill.Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes.Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.Combination therapy for Gram-negative bacteria: what is the evidence?Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases.Distribution of Class I Integron and smqnr Resistance Gene Among Stenotrophomonas maltophilia Isolated from Clinical Samples in Iran.A Combination of Trimethoprim-sulfamethoxazole and Ceftazidime Showed Good In Vitro Activity against Stenotrophomonas maltophilia.In vitro evaluation of the effect of linezolid and levofloxacin on Bacillus anthracis toxin production, spore formation and cell growth.Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia.Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas maltophilia isolates.A Combination of Trimethoprim-sulfamethoxazole and Ceftazidime Showed Good In Vitro Activity against Stenotrophomonas maltophilia.Stenotrophomonas maltophilia bacteraemia in Turkish children.Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy.Pharmacokinetic/pharmacodynamic parameters for treatment optimization of infection due to antibiotic resistant bacteria: a summary for practical purposes in children and adults.Stenotrophomonas maltophilia CSF infection in infants after neurosurgery.
P2860
Q26995336-DD48BC7A-77AD-4838-830B-16F638249B9DQ28550910-601EE863-19E7-4CE8-AC58-33F18EB6D025Q33652427-FEA1BFF1-12F1-4387-90AD-65D43BED2556Q37302998-F7B93FD4-A1FD-4EE7-B727-DF68A795C33EQ37866819-583140A3-B08D-4DCA-8563-1464C94E5730Q38156194-6ABD573C-50ED-45DA-B617-7DD43B08C300Q38188881-9D0E6B64-7E23-4C65-8A6A-52274831875BQ38679892-0C98AB12-C923-4F6C-8B09-67BBFDD36F46Q40052282-E55CF762-98F8-4C69-8466-27C1F86163ABQ40474328-673D075B-F60A-4D88-B21A-E146CF6E439AQ42003718-F15E570E-5B5F-4336-A9DF-E0BF323504B5Q44066415-304D0C07-0AD1-4E57-9CEB-8113B2E4E37BQ46022876-DF622B1B-7204-43A9-9205-B49CA22F5839Q46568928-3CB09BCC-9618-4EA6-A164-61F95B5F4A6CQ47126542-80229445-2658-4BCB-BA38-88AAB17F4BDBQ48197188-6525CBD8-1130-45AB-825E-A4D64BBBF40CQ52804941-17416EE8-BB2B-4A22-892E-B34B3496D0F5
P2860
Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Antibiotic combinations signif ...... Stenotrophomonas maltophilia.
@en
Antibiotic combinations signif ...... Stenotrophomonas maltophilia.
@nl
type
label
Antibiotic combinations signif ...... Stenotrophomonas maltophilia.
@en
Antibiotic combinations signif ...... Stenotrophomonas maltophilia.
@nl
prefLabel
Antibiotic combinations signif ...... Stenotrophomonas maltophilia.
@en
Antibiotic combinations signif ...... Stenotrophomonas maltophilia.
@nl
P50
P1476
Antibiotic combinations signif ...... Stenotrophomonas maltophilia.
@en
P2093
Godfrey K M Harding
P356
10.1016/J.DIAGMICROBIO.2004.09.002
P577
2005-01-01T00:00:00Z